These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27904075)

  • 1. In Vitro Permeation and Skin Retention of α-Mangostin Proniosome.
    Chin GS; Todo H; Kadhum WR; Hamid MA; Sugibayashi K
    Chem Pharm Bull (Tokyo); 2016; 64(12):1666-1673. PubMed ID: 27904075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and evaluation of proniosomes containing lornoxicam.
    Madan JR; Ghuge NP; Dua K
    Drug Deliv Transl Res; 2016 Oct; 6(5):511-8. PubMed ID: 27255375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nano-proniosomes enhancing the transdermal delivery of mefenamic acid.
    Wen MM; Farid RM; Kassem AA
    J Liposome Res; 2014 Dec; 24(4):280-9. PubMed ID: 24779560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of methotrexate loaded niosomes by Box-Behnken design: an understanding of solvent effect and formulation variability.
    Zidan AS; Mokhtar Ibrahim M; Megrab NAE
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1450-1459. PubMed ID: 28420295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel non-ionic surfactant proniosomes for transdermal delivery of lacidipine: optimization using 2(3) factorial design and in vivo evaluation in rabbits.
    Soliman SM; Abdelmalak NS; El-Gazayerly ON; Abdelaziz N
    Drug Deliv; 2016 Jun; 23(5):1608-22. PubMed ID: 26758033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of proniosomes as an alternative strategy to optimize piroxicam transdermal delivery.
    Alsarra IA
    J Microencapsul; 2009 May; 26(3):272-8. PubMed ID: 18720197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro skin permeation of estradiol from various proniosome formulations.
    Fang JY; Yu SY; Wu PC; Huang YB; Tsai YH
    Int J Pharm; 2001 Mar; 215(1-2):91-9. PubMed ID: 11250095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal delivery of haloperidol by proniosomal formulations with non-ionic surfactants.
    Azarbayjani AF; Tan EH; Chan YW; Chan SY
    Biol Pharm Bull; 2009 Aug; 32(8):1453-8. PubMed ID: 19652389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentials of proniosomes for improving the oral bioavailability of poorly water-soluble drugs.
    Song S; Tian B; Chen F; Zhang W; Pan Y; Zhang Q; Yang X; Pan W
    Drug Dev Ind Pharm; 2015 Jan; 41(1):51-62. PubMed ID: 24111828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proniosome-derived niosomes for tacrolimus topical ocular delivery: in vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection.
    Li Q; Li Z; Zeng W; Ge S; Lu H; Wu C; Ge L; Liang D; Xu Y
    Eur J Pharm Sci; 2014 Oct; 62():115-23. PubMed ID: 24905830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study on the effects of some polyoxyethylene alkyl ether and sorbitan fatty acid ester surfactants on the performance of transdermal carvedilol proniosomal gel using experimental design.
    Aboelwafa AA; El-Setouhy DA; Elmeshad AN
    AAPS PharmSciTech; 2010 Dec; 11(4):1591-602. PubMed ID: 21063815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and optimization of boswellic acid-loaded proniosomal gel.
    Mehta M; Dureja H; Garg M
    Drug Deliv; 2016 Oct; 23(8):3072-3081. PubMed ID: 26953869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proniosomes as a drug carrier for transdermal delivery of ketorolac.
    Alsarra IA; Bosela AA; Ahmed SM; Mahrous GM
    Eur J Pharm Biopharm; 2005 Apr; 59(3):485-90. PubMed ID: 15760729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies.
    El-Laithy HM; Shoukry O; Mahran LG
    Eur J Pharm Biopharm; 2011 Jan; 77(1):43-55. PubMed ID: 21056658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved skin permeation of transferosomes containing Eulophia macrobulbon extract.
    Potisuwan S; Apichatwatana N; Rujivipat S
    Colloids Surf B Biointerfaces; 2023 Sep; 229():113474. PubMed ID: 37540959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and evaluation of a proniosome hydrocortisone gel in comparison with a commercial cream.
    Sankar V; Praveen C; Prasanth KG; Srinivas CR; Ruckmann K
    Pharmazie; 2009 Nov; 64(11):731-4. PubMed ID: 20099517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEGylated non-ionic surfactant vesicles as drug delivery systems for Gambogenic acid.
    Lin T; Fang Q; Peng D; Huang X; Zhu T; Luo Q; Zhou K; Chen W
    Drug Deliv; 2013; 20(7):277-84. PubMed ID: 24044645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal delivery of flurbiprofen from surfactant-based vesicles: particle characterization and the effect of water on in vitro transport.
    Uchino T; Matsumoto Y; Murata A; Oka T; Miyazaki Y; Kagawa Y
    Int J Pharm; 2014 Apr; 464(1-2):75-84. PubMed ID: 24445120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced oral bioavailability of isradipine via proniosomal systems.
    Veerareddy PR; Bobbala SK
    Drug Dev Ind Pharm; 2013 Jun; 39(6):909-17. PubMed ID: 22998221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and evaluation of niosome gel containing acyclovir for enhanced dermal deposition.
    Jacob S; Nair AB; Al-Dhubiab BE
    J Liposome Res; 2017 Dec; 27(4):283-292. PubMed ID: 27558522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.